Numerous lines of evidence from human genetics, human pathology, cell based systems and animal models have implicated dysregulation of alpha-synuclein as an underlying driver of neurodegeneration in Parkinson’s disease and other synucleinopathies including multiple system atrophy and dementia with Lewy bodies1–3. The gene discussed is SNCA; the disease is Parkinson disease.